ELVN logo

Enliven Therapeutics, Inc. (ELVN) Return On Assets

Annual ROA:

-29.79%+9.56%(+24.29%)
December 31, 2024

Summary

  • As of today, ELVN annual return on assets is -29.79%, with the most recent change of +9.56% (+24.29%) on December 31, 2024.
  • During the last 3 years, ELVN annual ROA has fallen by -5.56% (-22.95%).
  • ELVN annual ROA is now -1479.17% below its all-time high of 2.16%, reached on December 1, 2017.

Performance

ELVN ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNprofitability metrics

Quarterly ROA:

-25.20%+3.19%(+11.24%)
September 30, 2025

Summary

  • As of today, ELVN quarterly return on assets is -25.20%, with the most recent change of +3.19% (+11.24%) on September 30, 2025.
  • Over the past year, ELVN quarterly ROA has increased by +2.81% (+10.03%).
  • ELVN quarterly ROA is now -583.69% below its all-time high of 5.21%, reached on December 31, 2022.

Performance

ELVN Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNprofitability metrics

ROA Formula

ROA =  Net Income
Total Assets
✕ 100%

ELVN ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+24.3%+10.0%
3Y3 Years-22.9%+51.8%
5Y5 Years+74.0%+25.9%

ELVN ROA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-2154.5%+24.3%-583.7%+51.8%
5Y5-Year-2154.5%+74.0%-583.7%+56.3%
All-TimeAll-Time-1479.2%+76.5%-583.7%+56.3%

ELVN ROA History

DateAnnualQuarterly
Sep 2025
-
-25.20%(+11.2%)
Jun 2025
-
-28.39%(+4.0%)
Mar 2025
-
-29.57%(-4.5%)
Dec 2024
-29.79%(+24.3%)
-28.30%(-1.0%)
Sep 2024
-
-28.01%(-1.7%)
Jun 2024
-
-27.53%(-2.4%)
Mar 2024
-
-26.89%(+7.7%)
Dec 2023
-39.35%(-2813.8%)
-29.12%(-195.6%)
Sep 2023
-
-9.85%(-62.0%)
Jun 2023
-
-6.08%(-268.5%)
Mar 2023
-
-1.65%(-131.7%)
Dec 2022
1.45%
5.21%(+110.0%)
Sep 2022
-
-52.25%(+3.7%)
DateAnnualQuarterly
Jun 2022
-
-54.27%(+4.9%)
Mar 2022
-
-57.05%(+1.0%)
Dec 2021
-24.23%(+63.6%)
-
Dec 2021
-
-57.65%(-7.3%)
Sep 2021
-
-53.72%(-3.6%)
Jun 2021
-
-51.87%(-15.5%)
Mar 2021
-
-44.91%(-12.0%)
Dec 2020
-66.63%(+41.8%)
-40.09%(-17.9%)
Sep 2020
-
-33.99%(-56.7%)
Jun 2020
-
-21.69%(-73.0%)
Mar 2020
-
-12.54%
Dec 2019
-114.45%(+9.5%)
-
Dec 2018
-126.47%(-5955.1%)
-
Dec 2017
2.16%
-

FAQ

  • What is Enliven Therapeutics, Inc. annual return on assets?
  • What is the all-time high annual ROA for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. annual ROA year-on-year change?
  • What is Enliven Therapeutics, Inc. quarterly return on assets?
  • What is the all-time high quarterly ROA for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. quarterly ROA year-on-year change?

What is Enliven Therapeutics, Inc. annual return on assets?

The current annual ROA of ELVN is -29.79%

What is the all-time high annual ROA for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high annual return on assets is 2.16%

What is Enliven Therapeutics, Inc. annual ROA year-on-year change?

Over the past year, ELVN annual return on assets has changed by +9.56% (+24.29%)

What is Enliven Therapeutics, Inc. quarterly return on assets?

The current quarterly ROA of ELVN is -25.20%

What is the all-time high quarterly ROA for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high quarterly return on assets is 5.21%

What is Enliven Therapeutics, Inc. quarterly ROA year-on-year change?

Over the past year, ELVN quarterly return on assets has changed by +2.81% (+10.03%)
On this page